ArticleMedComm2024

Structure-based design of antibodies targeting the EBNA1 DNA-binding domain to block Epstein-Barr virus latent infection and tumor growth.

Yongyue Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.